Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude mouse

@article{Johansen1981DoxorubicinPA,
  title={Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude mouse},
  author={Peter B. Johansen},
  journal={Cancer Chemotherapy and Pharmacology},
  year={1981},
  volume={5},
  pages={267-270}
}
SummaryThe pharmacokinetics of doxorubicin in nude mice have been investigated following intravenous and intraperitoneal administration of single doses of 12 mg/kg. The areas under the concentration curves of doxorubicin in kidney, heart, and striated muscle following intraperitoneal administration were approximately half the areas following intravenous injection, whereas plasma and liver showed nearly identical concentrations after a distribution phase of 2 h. Only minor differences in… CONTINUE READING

Figures and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 34 CITATIONS

Doxorubicin Has Dose-Dependent Toxicity on Mouse Ovarian Follicle Development, Hormone Secretion, and Oocyte Maturation.

  • Toxicological sciences : an official journal of the Society of Toxicology
  • 2017
VIEW 1 EXCERPT
HIGHLY INFLUENCED

Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation.

  • Journal of controlled release : official journal of the Controlled Release Society
  • 2017
VIEW 1 EXCERPT
CITES METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 11 REFERENCES

Biodistribution of intravenously injected [14C] doxorubicin and [14C] daunorubicin in mice: concise communication.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 1978
VIEW 1 EXCERPT

Comparative effect of intravenous and intraperitoneal adriamycin on metastatic Dunn osteosarcoma

DW Siemann, RM Sutherland
  • Proc Am Assoc Cancer Res
  • 1977

On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors

L Lenaz, A Di Marco
  • Cancer Chemother Rep
  • 1972
VIEW 1 EXCERPT